Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Deykin

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|April 15, 1988
Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2R M Kramer, J A Jakubowski, D Deykin
British Journal of Haematology|July 1, 1976
Quantitative determination of factor-VIII protein by two-stage gel electrophoresisM J Weinstein, D Deykin, E W Davie
The New England Journal of Medicine|January 1, 1976
Letter: Limulus testJ Fine, D Deykin, J Ansell, et al.
American Journal of Hematology|January 1, 1977
A chlorpromazine-induced inhibitor of blood coagulationR T Canoso, R A Hutton, D Deykin
Blood|February 1, 1973
Platelet dysfunction in glycogen storage disease type IE E Czapek, D Deykin, E W Salzman
Biochimica Et Biophysica Acta|October 3, 1986
Incorporation and redistribution of arachidonic acid in diacyl and ether phospholipids of bovine aortic endothelial cellsH E Wey, J A Jakubowski, D Deykin
Blood|October 1, 1980
Platelet arachidonic acid metabolism and platelet function in ten patients with chronic myelogenous leukemiaS J Jubelirer, F Russel, R Vaillancourt, et al.
Chest|October 1, 1992
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic rangeJ Hirsh, J E Dalen, D Deykin, et al.
Chest|October 1, 1992
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safetyJ Hirsh, J E Dalen, D Deykin, et al.
Thrombosis Research|December 15, 1993
Characterization of phospholipase A2 secretion from human plateletsH W Mueller, C R Pritzker, A Kubik, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|April 15, 1988
Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2R M Kramer, J A Jakubowski, D Deykin
British Journal of Haematology|July 1, 1976
Quantitative determination of factor-VIII protein by two-stage gel electrophoresisM J Weinstein, D Deykin, E W Davie
The New England Journal of Medicine|January 1, 1976
Letter: Limulus testJ Fine, D Deykin, J Ansell, et al.
American Journal of Hematology|January 1, 1977
A chlorpromazine-induced inhibitor of blood coagulationR T Canoso, R A Hutton, D Deykin
Blood|February 1, 1973
Platelet dysfunction in glycogen storage disease type IE E Czapek, D Deykin, E W Salzman
Biochimica Et Biophysica Acta|October 3, 1986
Incorporation and redistribution of arachidonic acid in diacyl and ether phospholipids of bovine aortic endothelial cellsH E Wey, J A Jakubowski, D Deykin
Blood|October 1, 1980
Platelet arachidonic acid metabolism and platelet function in ten patients with chronic myelogenous leukemiaS J Jubelirer, F Russel, R Vaillancourt, et al.
Chest|October 1, 1992
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic rangeJ Hirsh, J E Dalen, D Deykin, et al.
Chest|October 1, 1992
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safetyJ Hirsh, J E Dalen, D Deykin, et al.
Thrombosis Research|December 15, 1993
Characterization of phospholipase A2 secretion from human plateletsH W Mueller, C R Pritzker, A Kubik, et al.
Pageof 14